The Profound Impacts of Precision Medicine, Genomic Sequencing on Cancer Care
Precision Oncology is helping NCI treat cancer based on specific genetic changes in a patient’s tumor by allowing them to target mutations that will lower toxicity and improve overall effectiveness of the treatment.
A clinical trial at the National Cancer Institute called NCI-MATCH showed how cancer patients could benefit from genomic sequencing and is now informing future trials on precision medicine.
The NCI Molecular Analysis for Therapy Choice Trial initially screened 6,000 patients and treated 1,300 of them by pairing certain medications with their specific tumors regardless of the cancer type. Future trials like ComboMATCH will now look at precision medicine to study how tumors respond to targeted treatments.
NCI Researchers Dr. Lindsay Harris and Dr. Peter O’Dwyer shared how precision oncology is expanding treatment options and increasing patients’ survival rates. They also discuss the importance of clinical trials like these for progressing the fight against cancer.
-
Dr. Lyndsay Harris Associate Director, Cancer Diagnosis Program NCI -
Dr. Peter O'Dwyer Group Co-Chair ECOG-ACRIN Cancer Research Group
-
Library of Congress, NARA Modernize Records Management with Emerging Tech
Natalie Buda Smith and Jill Reilly dive into the challenges of preserving and providing access to digital-native materials.
19m listen -
DHS Leads Government’s Largest Civilian AI Hiring Effort
On this AI GovCast miniseries, Boyce discusses his journey to the agency with his prior roles at the Office of Management and Budget.
15m listen -
Storytelling Miniseries: Using Narratives to Nurture Relationships
In the final episode of our Storytelling Miniseries, we discuss building meaningful relationships through storytelling.
20m listen -
How AI Improves Decision-Making and Workload at Borders
Customs and Border Protection CTO Sunil Madhugiri discussed how the agency is using artificial intelligence at the nation’s borders.
19m listen
